Hodgkin Lymphoma: Intensifying Treatment With Rituximab After PET
Adjusting treatment dose after 2 courses of first-line therapy based on a positive PET scan does not improve progression-free survival.
Adjusting treatment dose after 2 courses of first-line therapy based on a positive PET scan does not improve progression-free survival.
Treatment with anthracyclines increases the risk for developing heart failure by 3-fold independently of radiation dose among survivors of Hodgkin lymphoma.
A diagnosis of Waldenstrom’s Macroglobulinemia can leave you and your loved ones feeling uncertain, anxious and overwhelmed.
BeGEV appears to provide clinical benefit for patients with relapsed or refractory Hodgkin lymphoma, and ought to be developed further.
Early MRI-based screening may reduce breast cancer mortality among women treated with radiotherapy (RT) for childhood Hodgkin lymphoma.
Hodgkin lymphoma incidence was lower in areas of the United States with more ultraviolet radiation exposure.
Patients with advanced-stage Hodgkin lymphoma who were at high risk for treatment failure as determined by interim PET response.
Standard ABVD was associated with a significant improvement in survival in older patients with Hodgkin lymphoma.
Significant disparities have been found in HIV-positive black patients with Hodgkin lymphoma, with regard to both rate of diagnosis and chemotherapy usage.
Patients with advanced Hodgkin lymphoma treated with BEACOPP or CEC did not show a progression-free survival.